CD274 and neoplasm: Bensch et al. investigated [89Zr]-Atezolizumab-based PD-L1 imaging and found that tumour uptake but not histological PD-L1 expression predicted patients’ survival under ICI treatment with an extremely inhomogeneous SUVmax distribution in the same patient (28).